Medtronic, Inc.has announced the initiation of a feasibility study of an interventional treatment for erectile dysfunction that uses a specially-designed drug-eluting stent system.
Boston Scientific Corporation has completed enrollment in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures.
The Cochrane Collaboration urges free access to all data from all clinical trials: end to selective reporting can reduce the risk of harm to patients
In a study published in the October 4 issue of Annals of Internal Medicine, cardiologists at Johns Hopkins report that a protocol they developed has proved effective in enabling patients with implanted cardiac devices to safely undergo an MRI scan.
First Ever Randomized, Controlled Clinical Trial in Persistent Atrial Fibrillation (AF) Patients
bbott’s EXCEL is the Largest Trial to Date Designed to Evaluate Optimal Treatment Strategy (Surgery or Stenting) in Patients with Unprotected Left Main Disease
Boston Scientific commences study designed to assess preliminary safety and efficacy of chronic vagal nerve stimulation in heart failure patients
Flexible Stenting Solutions Inc. has announced the successful treatment of the first two patients enrolled in the OPEN (Evaluation of Safety and Efficacy of the FlexStent(R) FemorOPopliteal Self-Expanding StENt System) clinical trial.
Performance for the controversial metal-on-metal (MoM) hip replacement devices continues to create cause for concern, particularly in women, according to this year’s National Joint Registry (NJR) Annual Report.
2011 REPORT OF NATIONAL JOINT REGISTRY OF ENGLAND AND WALES CONFIRMS SUCCESS OF DEPUY JOINT REPLACEMENT PRODUCTS
Carotid stent use “Quality of Life” benefits were reduced to equivalence compared with surgery at the one year time point in a 2500 patient randomized multicentre study.
Definitive data confirms that use of the Pulmonx Chartis® Pulmonary Assessment System to plan Zephyr® Endobronchial Valve (EBV) treatments is the key to successful EBV treatment of emphysema.
BIOTRONIK has announced the completion of enrollment in the BIOLUX P-I – a clinical study investigating the use of a drug-eluting balloon (DEB) catheter, a promising new approach to treating disease in the more challenging peripheral vascular anatomy.
Biotronik PREVENT study indicates lower percent of right ventricular pacing (%VP) correlates with less risk of heart failure (HF) hospitalization, mortality and atrial fibrillation (AF)
Covidien has announced the start of patient enrollment in the ev3 DEFINITIVE(TM) Anti-Restenosis study taking place at Imelda Hospital in Belgium with Dr. Patrick Peeters.
Covidien has announced the completion of enrollment of 600 patients in its post-marketing study comparing outcomes of inguinal hernia repair with self-fixating mesh to gold-standard repair technique using sutures